These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27576500)

  • 1. The Tyranny of Generic Immunosuppressants.
    Ravichandran B; Weir MR
    Am J Nephrol; 2016; 44(3):204-5. PubMed ID: 27576500
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic immunosuppressants in hematopoietic cell transplantation.
    Cutler C; Kesselheim A; Gabardi S; Andersson BS; Carpenter P; Khoury HJ; Litzow M; Rowley SD; Lanum S; Leather H; Tina Shih YC; Gale RP; Wingard JR; Appelbaum FR; Anasetti C;
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):285-90. PubMed ID: 21087678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Special considerations in generic substitution of immunosuppressive drugs in transplantation].
    Remport A; Dankó D; Gerlei Z; Czebe K; Kiss I
    Orv Hetil; 2012 Aug; 153(34):1341-9. PubMed ID: 22913916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem with generic immunosuppressants.
    Filler G; Kobrzyński M
    Pediatr Transplant; 2014 Sep; 18(6):551-3. PubMed ID: 25123955
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic clopidogrel: time to substitute?
    Doll J; Zeitler E; Becker R
    JAMA; 2013 Jul; 310(2):145-6. PubMed ID: 23839745
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
    Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
    Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversy over generic substitution.
    Ferner RE; Lenney W; Marriott JF
    BMJ; 2010 Jun; 340():c2548. PubMed ID: 20516014
    [No Abstract]   [Full Text] [Related]  

  • 8. Generic immunosuppression in transplantation: current evidence and controversial issues.
    El Hajj S; Kim M; Phillips K; Gabardi S
    Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs.
    van Gelder T; Gabardi S
    Transpl Int; 2013 Aug; 26(8):771-7. PubMed ID: 23441971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugs.
    van Gelder T;
    Transpl Int; 2011 Dec; 24(12):1135-41. PubMed ID: 22032583
    [No Abstract]   [Full Text] [Related]  

  • 12. Is all "skin in the game" fair game? The problem with "non-preferred" generics.
    Oster G; Fendrick AM
    Am J Manag Care; 2014 Sep; 20(9):693-5. PubMed ID: 25365744
    [No Abstract]   [Full Text] [Related]  

  • 13. Generic medicines in the Malaysian health care system: Opportunities and challenges.
    Wong ZY; Alrasheedy AA; Hassali MA; Saleem F
    Res Social Adm Pharm; 2016; 12(5):807-10. PubMed ID: 27157864
    [No Abstract]   [Full Text] [Related]  

  • 14. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?
    Phillips K; Reddy P; Gabardi S
    J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic drug products in paediatrics: Where are the data?
    Illamola SM; Birnbaum AK; Sherwin CM
    Br J Clin Pharmacol; 2019 Sep; 85(9):1871-1873. PubMed ID: 31281980
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic immunosuppressants: the European perspective.
    Christians U
    Transplant Proc; 1999 May; 31(3A Suppl):19S-22S. PubMed ID: 10330954
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic drugs for the treatment of ocular conditions: changing the treatment landscape.
    Aref AA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic maintenance immunosuppression in solid organ transplant recipients.
    Ensor CR; Trofe-Clark J; Gabardi S; McDevitt-Potter LM; Shullo MA
    Pharmacotherapy; 2011 Nov; 31(11):1111-29. PubMed ID: 22026398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Future of Generics in Transplantation?
    van Gelder T
    Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.